$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
Amgen to Buy Celgene's Otezla: 5 ETF Drugs
02:05pm, Tuesday, 27'th Aug 2019
Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.
Strong July Gives Way To Volatile August As Trade War Escalates
12:00am, Wednesday, 07'th Aug 2019Biotech ETFs in Focus on Impressive Q2 Earnings Results
08:22pm, Tuesday, 06'th Aug 2019
Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q2 earnings results recently.
AbbVie to Buy Allergan: Prescribed ETFs
03:00pm, Wednesday, 26'th Jun 2019
AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.
3 Large-Cap Biotech Stocks to Buy for Massive Gains
03:49pm, Wednesday, 19'th Jun 2019
Do you want to find the next Apple (NASDAQ:AAPL) or Amazon (NASDAQ:AMZN)? My advice is that you should set your sights lower, not higher and put some cash to work in three down, but not out heavyweigh
Sign In
Buy BBH